Drug Type Gene therapy, Hematopoietic stem cell therapy |
Synonyms OTL-102 |
Target |
Mechanism CYBB gene stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Granulomatous Disease, Chronic | Phase 2 | GB | 30 Sep 2021 |